Growth Metrics

Exact Sciences (EXAS) Receivables - Net (2016 - 2025)

Exact Sciences has reported Receivables - Net over the past 12 years, most recently at $298.7 million for Q4 2025.

  • Quarterly Receivables - Net rose 19.96% to $298.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $298.7 million through Dec 2025, up 19.96% year-over-year, with the annual reading at $298.7 million for FY2025, 19.96% up from the prior year.
  • Receivables - Net was $298.7 million for Q4 2025 at Exact Sciences, down from $306.1 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $353.3 million in Q2 2025 and troughed at $158.0 million in Q4 2022.
  • The 5-year median for Receivables - Net is $233.6 million (2021), against an average of $235.5 million.
  • Year-over-year, Receivables - Net skyrocketed 82.89% in 2021 and then decreased 27.05% in 2022.
  • A 5-year view of Receivables - Net shows it stood at $216.6 million in 2021, then dropped by 27.05% to $158.0 million in 2022, then increased by 28.84% to $203.6 million in 2023, then grew by 22.27% to $249.0 million in 2024, then rose by 19.96% to $298.7 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Receivables - Net are $298.7 million (Q4 2025), $306.1 million (Q3 2025), and $353.3 million (Q2 2025).